Showing results (1-10 of 103) with videos related to
Sort By:
Pageof 11
Current Opinion in Rheumatology|October 24, 2008
Animal models in myositisYasuhiro Katsumata, Dana P AschermanClinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine|October 9, 2015
Interstitial Lung Disease with ANCA-associated VasculitisYasuhiro Katsumata, Yasushi Kawaguchi, Hisashi YamanakaLupus|June 26, 2026
Continuation of belimumab in patients with systemic lupus erythematosus in a real-world setting: A single-center retrospective cohort studyNatsuko Hara, Yuko Okamoto, Yasuhiro KatsumataBrain and Nerve = Shinkei Kenkyu No Shinpo|November 9, 2013
[Idiopathic inflammatory myopathies from the viewpoint of rheumatologists]Takahisa Gono, Yasuhiro Katsumata, Yasushi KawaguchiInternational Journal of Rheumatic Diseases|July 1, 2025
Comparison of Outcomes Between Protocolized Tacrolimus-Based and Non-Protocolized Ciclosporin-Based Triple-Combination Therapy in Interstitial Lung Disease With Anti-MDA5-Positive Dermatomyositis: A Single-Center Retrospective Cohort StudyRisa Yamada, Masayoshi Harigai, Yasuhiro KatsumataLupus|April 16, 2024
Upregulation of PD-1 and its ligands and expansion of T peripheral helper cells in the nephritic kidneys of lupus-prone BXSB-<i>Yaa</i> miceRina Moriyama, Yasuhiro Katsumata, Yuko Okamoto, et al.Plos Computational Biology|November 22, 2008
Structural and thermodynamic approach to peptide immunogenicityCarlos J Camacho, Yasuhiro Katsumata, Dana P AschermanModern Rheumatology|November 29, 2018
KL-6 is a long-term disease-activity biomarker for interstitial lung disease associated with polymyositis/dermatomyositis, but is not a short-term disease-activity biomarkerMasanori Hanaoka, Yasuhiro Katsumata, Hidenaga Kawasumi, et al.Immunology Letters|August 8, 2025
A shared monocyte cytokine signature induced by serum from patients with systemic lupus erythematosus and anti-MDA5 antibody-positive dermatomyositis through the type I interferon pathwayShohei Nakamura, Yuko Okamoto, Hideto Takada, et al.Modern Rheumatology|September 29, 2020
Validation of the Japanese version of the Lupus Damage Index Questionnaire in a large observational cohort: A two-year prospective studyYuko Okamoto, Yasuhiro Katsumata, Sayumi Baba, et al.Pageof 11